RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
Updated evidence report and systematic review for the US Preventive Services Task Force
Asher, G. N., Feltner, C., Harrison, W. N., Schwimmer, E., Rains, C., & Jonas, D. E. (2023). Serologic screening for genital herpes: Updated evidence report and systematic review for the US Preventive Services Task Force. JAMA, 329(6), 510-512. https://doi.org/10.1001/jama.2022.20356
This systematic review to support the 2023 US Preventive Services Task Force Recommendation Statement on serologic screening for genital herpes summarizes published evidence on the benefits and harms of screening and interventions for genital herpes in asymptomatic sexually active adolescents, adults, and pregnant persons with no clinical history of genital herpes.
